Avibactam Impurity 5, chemically (2S,5R)-5-((benzyloxy)amino)piperidine-2-carboxylic acid, is a chiral piperidine-based carboxylic acid that serves as a key process-related impurity and a critical synthetic intermediate for the blockbuster β‑lactamase inhibitor Avibactam. The molecule features a stereochemically defined (2S,5R) configuration, a free carboxylic acid group at the 2-position, and a benzyloxyamino substituent at the 5-position of the piperidine ring. This precise stereochemical architecture positions Avibactam Impurity 5 as an essential reference standard for pharmaceutical quality control and a valuable building block in the development of next‑generation diazabicyclooctane (DBO) β‑lactamase inhibitors.
Avibactam Impurity 5 (CAS 1501980-29-5), also known as (2S,5R)-5-((benzyloxy)amino)piperidine-2-carboxylic acid, Avibactam Impurity B, Avibactam Impurity 40, Avibactam Impurity 38, and Avibactam Impurity 25, is a chiral organic compound belonging to the class of piperidine carboxylic acids. The molecular formula is C₁₃H₁₈N₂O₃ with a molecular weight of 250.29 g/mol, and the compound is typically supplied at purities of 98% to 99% as a white to off‑white solid.
Avibactam Impurity 5 is both a critical intermediate in the synthesis of Avibactam sodium and a process-related impurity that may arise during the manufacturing of this clinically important β‑lactamase inhibitor. The (2S,5R) stereochemistry of Avibactam Impurity 5 is essential for the eventual biological activity of Avibactam, as the correct spatial orientation enables proper binding to the active site of serine β‑lactamase enzymes, leading to irreversible inhibition. The presence of Avibactam Impurity 5 during synthesis, if not properly controlled, can indicate incomplete reaction progression or the formation of stereoisomeric side products.
During Avibactam sodium manufacturing, Avibactam Impurity 5 may arise from several sources, including the incomplete formation of the oxyaminopiperidine intermediate, partial degradation of downstream intermediates, or carryover from incomplete chiral resolution steps. As a result, Avibactam Impurity 5 is listed among the suite of controlled impurities for Avibactam drug substance, with strict specifications enforced to ensure the safety, efficacy, and stability of the final pharmaceutical product.
In pharmaceutical quality control, Avibactam Impurity 5 is widely used as an impurity reference standard for analytical method development, method validation (AMV), quality control (QC) applications, and abbreviated new drug application (ANDA) submissions during the commercial production of Avibactam. The reference standard is supplied with comprehensive characterization data, including HPLC purity profiles, NMR spectra, and mass spectrometry confirmation, compliant with regulatory guidelines from ICH, FDA, and EMA.
Beyond its role as an impurity standard, Avibactam Impurity 5 serves as a versatile building block for the synthesis of novel diazabicyclooctane (DBO) derivatives with potential activity against emerging β‑lactamase variants, such as KPC, OXA‑48, and NDM carbapenemases that are driving the global crisis of antimicrobial resistance (AMR).
Product Parameters
Parameter
Specification
CAS Number
1501980-29-5
Molecular Formula
C₁₃H₁₈N₂O₃
Molecular Weight
250.29 g/mol
Purity
98% as standard; 99% available upon request
Appearance
White to off-white solid
Density
1.2 ± 0.1 g/cm³ (Predicted)
Boiling Point
431.1 ± 55.0 °C at 760 mmHg (Predicted)
Flash Point
214.5 ± 31.5 °C (Predicted)
Refractive Index
1.580 (Predicted)
Complexity
267
Solubility
Slightly soluble in water; soluble in DMSO, DMF, and methanol
Storage Condition
Inert atmosphere (nitrogen or argon), room temperature, protected from light and moisture
Stability
Stable for up to 24 months when stored at 2–8 °C in sealed, moisture-proof containers
GHS Signal Word
Warning
Hazard Statements
H302 (Harmful if swallowed); H315 (Causes skin irritation); H319 (Causes serious eye irritation); H335 (May cause respiratory irritation)
Canonical SMILES
C1CC@HC(=O)O
Quality Assurance at Cosperpharm
Each batch undergoes:
● Gas chromatography (GC) – purity ≥97.0%
● Non‑aqueous titration – purity ≥97.0%
● Refractive index – confirmatory analysis
● ¹H NMR – structural verification
● Appearance – colorless to light yellow to light orange clear liquid
A comprehensive COA, MSDS (with full GHS information), and certificate of origin accompany every shipment.
Why Cosperpharm? – Our Competitive Advantages
Advantage
Detail
Production Strength
GMP-certified campus spanning 100+ mu, 3 multi-purpose workshops, 6 D-grade clean zone production lines, and 150+ reactors (20L–5000L), supporting high/low temp, anaerobic & hydrogenation; kg to ton scale production.
Fast Delivery
R&D samples: one week; commercial orders: 1–2 months after payment. Express (DHL/FedEx) or air/sea freight available.
Global Partners
Trusted by 30+ pharmaceutical companies in USA, Europe, India, Brazil, and Southeast Asia; long-term cooperation with generic drug manufacturers, CROs, and impurity standard distributors.
Licensed Exporter
Valid drug import/export license — no compliance delays.
Dual Quality Grades
Both research/pharma grade(≥98%)and high-purity impurity grade(≥99%)available to meet diverse customer needs.
Product Advantages
● Official Avibactam impurity reference standard – Avibactam Impurity 5 is recognized as Avibactam Impurity B, Impurity 25, Impurity 38, and Impurity 40, making it a critical quality control standard for Avibactam drug substance and drug product. The reference standard is supplied with comprehensive characterization data, including HPLC purity profiles, NMR spectra, and mass spectrometry confirmation, compliant with ICH, FDA, and EMA regulatory guidelines.
● Key intermediate in Avibactam synthesis – Avibactam Impurity 5 is both a critical intermediate in the manufacture of Avibactam sodium and a process‑related impurity that may arise during its production. The (2S,5R) stereochemistry of Avibactam Impurity 5 is essential for the eventual biological activity of Avibactam, as the correct spatial orientation enables proper binding to the active site of serine β‑lactamase enzymes.
● Process‑related impurity monitoring – During Avibactam sodium manufacturing, Avibactam Impurity 5 may arise from the incomplete formation of the oxyaminopiperidine intermediate, partial degradation of downstream intermediates, or carryover from incomplete chiral resolution steps. Strict control of Avibactam Impurity 5 levels is essential to ensure the purity, safety, and regulatory compliance of the final Avibactam API.
● Analytical method development and validation – Avibactam Impurity 5 is used as an impurity reference standard for analytical method development, method validation (AMV), and quality control (QC) applications during ANDA submissions and commercial production of Avibactam.
● DBO β‑lactamase inhibitor development – Avibactam Impurity 5 serves as a versatile synthetic building block for constructing novel diazabicyclooctane (DBO) derivatives with potential activity against emerging β‑lactamase variants, including KPC, OXA‑48, and NDM carbapenemases, which are driving the global crisis of antimicrobial resistance (AMR).
● Well‑characterized – Registered in multiple impurity databases and supplied with comprehensive characterization data, enabling method validation, regulatory compliance, and quality assurance.
● High purity – Standard 98% ensures reliable and reproducible results; 99% grade available upon request.
● Stereochemically pure – Supplied as the pure (2S,5R) stereoisomer, ensuring accurate identification and quantification of diastereomeric impurities during chiral method development and QC testing.
Contact Us
We look forward to supporting your research and development needs.If you have any questions regarding Avibactam Impurity 5 (CAS 1501980-29-5) or wish to request a quotation, please do not hesitate to reach out. Our sales and technical support teams are ready to assist you.
Hot Tags: Avibactam Impurity 5, China, Manufacturer, Supplier, Factory
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies.
Privacy Policy